Symptom assessment in hypereosinophilic syndrome: Toward development of a patient-reported outcomes tool
- 14 May 2020
- journal article
- letter
- Published by Elsevier BV in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 8 (9), 3209-+
- https://doi.org/10.1016/j.jaip.2020.04.069
Abstract
No abstract availableFunding Information
- Division of Intramural Research, National Institute of Allergy and Infectious Diseases
- National Institutes of Health
- GlaxoSmithKline (HO-14-15311)
- ICON
- GlaxoSmithKline
This publication has 8 references indexed in Scilit:
- Patient-Reported Outcomes in Systemic Lupus ErythematosusRheumatic Disease Clinics of North America, 2016
- How I treat hypereosinophilic syndromesBlood, 2015
- Development and Validation of a Symptom-Based Activity Index for Adults With Eosinophilic EsophagitisGastroenterology, 2014
- Content Validity—Establishing and Reporting the Evidence in Newly Developed Patient-Reported Outcomes (PRO) Instruments for Medical Product Evaluation: ISPOR PRO Good Research Practices Task Force Report: Part 1—Eliciting Concepts for a New PRO InstrumentValue in Health, 2011
- Heterogeneity among characteristics of hypereosinophilic syndromesJournal of Allergy and Clinical Immunology, 2010
- Hypereosinophilic syndrome: A multicenter, retrospective analysis of clinical characteristics and response to therapyJournal of Allergy and Clinical Immunology, 2009
- The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature.1975
- THE HYPEREOSINOPHILIC SYNDROMEMedicine, 1975